Biomarkers and Predictive Factors in Breast Pathology: Translating Research into Clinical Practice
Biomarkers and Predictive Factors in Breast Pathology: Translating Research into Clinical Practice focuses on the critical role of biomarkers and predictive factors in breast pathology, aiming to bridge the gap between research discoveries and their practical application in clinical practice. The sessions within this track will explore the latest advancements in identifying and understanding biomarkers that aid in the diagnosis, prognosis, and treatment selection for breast cancer patients. From genomic and proteomic markers to hormone receptors and HER2/neu status, experts will discuss the clinical implications, validation studies, and guidelines for incorporating these biomarkers into routine practice. Attendees will gain valuable insights into how biomarkers and predictive factors are transforming breast pathology and enhancing personalized patient care.
- Biomarkers for Predicting Response to Therapy
- Prognostic Biomarkers in Breast Pathology
Related Conference of Biomarkers and Predictive Factors in Breast Pathology: Translating Research into Clinical Practice
April 13-14, 2026
23rd International Conference on Breast Pathology and Cancer Diagnosis
Tokyo, Japan
September 29-30, 2026
5th Experts Meeting on Cancer Medicine, Radiology & Treatment
Aix-en-Provence, France
Biomarkers and Predictive Factors in Breast Pathology: Translating Research into Clinical Practice Conference Speakers
Recommended Sessions
- Benign Breast Lesions: Diagnosis, Management, and Surveillance
- Biomarkers and Predictive Factors in Breast Pathology: Translating Research into Clinical Practice
- Breast Imaging: Innovations in Radiology and Pathology Correlation
- Breast Pathology in Pregnancy and Lactation: Challenges and Considerations
- Diagnostic Challenges: From Atypical Ductal Hyperplasia to Ductal Carcinoma In Situ
- Emerging Technologies in Breast Pathology: Digital Pathology, AI, and Machine Learning
- Immunohistochemistry and Biomarkers in Breast Pathology
- Inflammatory Breast Cancer: Pathogenesis, Diagnosis, and Therapeutic Advances
- Metastatic Breast Cancer: Pathological Insights and Treatment Approaches
- Molecular Pathology: Unraveling Breast Cancer Subtypes
- Multidisciplinary Approach to Breast Pathology: Collaboration between Pathologists, Radiologists, Surgeons, and Oncologists
- Pathological Assessment of Breast Core Biopsies: Pitfalls and Best Practices
- Pathological Assessment of Breast Reconstruction: Challenges and Surgical Considerations
- Pathology of Triple-Negative Breast Cancer: Clinical Implications and Therapeutic Strategies
- Precision Medicine in Breast Pathology: Integrating Genomics and Targeted Therapies
Related Journals
Are you interested in
- Advancement in the Field of Cancer - CANCER THERAPY MEETING 2026 (France)
- Advancements in Early Detection and Screening - Euro Breast Cancer 2025 (France)
- Advances in Breast Cancer Diagnosis - Breast Cancer Summit 2026 (France)
- Advances in Immuno-Oncology - CANCER THERAPY MEETING 2026 (France)
- Advances in Supportive Care and Symptom Management - CANCER THERAPY MEETING 2026 (France)
- Alternative Treatments and Therapeutics - Cancer Science 2026 (UAE)
- Artificial Intelligence & Big Data in Breast Oncology - Breast Cancer Summit 2026 (France)
- Artificial Intelligence and Big Data in Cancer Research - CANCER THERAPY MEETING 2026 (France)
- Artificial Intelligence and Digital Health in Oncology - Euro Breast Cancer 2025 (France)
- Artificial Intelligence in Breast Imaging - Breast Cancer-2026 (Italy)
- Breast Cancer - Cancer Science 2026 (UAE)
- Breast Cancer and Cell Biology - Breast Cancer 2026 (UAE)
- Breast Cancer and Immunology - Breast Cancer 2026 (UAE)
- Breast Cancer and Pregnancy - Breast Cancer Summit 2026 (France)
- Breast Cancer Awareness - Breast Cancer 2026 (UAE)
- Breast Cancer Biomarkers and Prognosis - Breast Cancer-2026 (Italy)
- Breast Cancer Clinical Trials - Breast Cancer 2026 (UAE)
- Breast Cancer Detection, Prevention, and Diagnosis - Breast Cancer 2026 (UAE)
- Breast Cancer Imaging and Radiology - Breast Cancer Summit 2026 (France)
- Breast Cancer in Men - Breast Cancer Summit 2026 (France)
- Breast Cancer in Men - Breast Cancer-2026 (Italy)
- Breast Cancer in Young Women - Breast Cancer Summit 2026 (France)
- Breast Cancer in Young Women - Euro Breast Cancer 2025 (France)
- Breast Cancer Management - Breast Cancer 2026 (UAE)
- Breast Cancer Nursing - Breast Cancer 2026 (UAE)
- Breast Cancer Prevention and Lifestyle - Breast Cancer Summit 2026 (France)
- Breast Cancer Prevention and Risk Reduction - Euro Breast Cancer 2025 (France)
- Breast Cancer Prevention Strategies - Breast Cancer-2026 (Italy)
- Breast Cancer Risk - Breast Cancer 2026 (UAE)
- Breast Cancer Staging - Breast Cancer 2026 (UAE)
- Breast Cancer Surgery - Breast Cancer 2026 (UAE)
- Breast Cancer Survivorship and Quality of Life - Breast Cancer-2026 (Italy)
- Breast Cancer Types and Etiology - Breast Cancer 2026 (UAE)
- Breast Reconstruction and Cosmetic Outcomes - Breast Cancer Summit 2026 (France)
- Breast Reconstruction and Cosmetic Surgery - Breast Cancer-2026 (Italy)
- Cancer Care in the Era of Digital Health - CANCER THERAPY MEETING 2026 (France)
- Cancer Control and Prevention - Cancer Science 2026 (UAE)
- Cancer Epidemiology and Prevention - CANCER THERAPY MEETING 2026 (France)
- Cancer Epigenetics - Cancer Science 2026 (UAE)
- Cancer Genomics & Metabolomics - CANCER THERAPY MEETING 2026 (France)
- Cancer Immunology - CANCER THERAPY MEETING 2026 (France)
- Cancer Metabolism and Therapeutic Interventions - CANCER THERAPY MEETING 2026 (France)
- Cancer Metastasis - Cancer Science 2026 (UAE)
- Cancer Science - Cancer Science 2026 (UAE)
- Cancer Stem Cells: Understanding and Targeting - CANCER THERAPY MEETING 2026 (France)
- Cancer Survivorship and Quality of Life - CANCER THERAPY MEETING 2026 (France)
- Cancer Vaccines - CANCER THERAPY MEETING 2026 (France)
- Cancers Biomarkers - Cancer Science 2026 (UAE)
- Cancers Pharmacology - Cancer Science 2026 (UAE)
- Case Studies - Breast Cancer 2026 (UAE)
- Cell-Based Therapy - CANCER THERAPY MEETING 2026 (France)
- Clinical Trials and New Drug Development - CANCER THERAPY MEETING 2026 (France)
- Diet and Lifestyle Effects on Breast Cancer - Breast Cancer 2026 (UAE)
- Drug Development and Clinical Trials in Breast Cancer - Euro Breast Cancer 2025 (France)
- Drug Resistance and Overcoming Challenges - CANCER THERAPY MEETING 2026 (France)
- Epidemiology of Breast Cancer and Risk Factors - Breast Cancer 2026 (UAE)
- Ethical and Regulatory Issues in Cancer Research - CANCER THERAPY MEETING 2026 (France)
- Future Directions in Cancer Therapy and Research - CANCER THERAPY MEETING 2026 (France)
- Genetic Predisposition and BRCA Mutations - Breast Cancer Summit 2026 (France)
- Global Disparities and Access to Breast Cancer Care - Euro Breast Cancer 2025 (France)
- Hematology- Oncology - Cancer Science 2026 (UAE)
- HER2-Positive Breast Cancer - Breast Cancer Summit 2026 (France)
- HER2-Positive Breast Cancer Advances - Breast Cancer-2026 (Italy)
- HER2-Positive Breast Cancer: Latest Treatment Strategies - Euro Breast Cancer 2025 (France)
- Hormone Receptor-Positive Breast Cancer - Breast Cancer Summit 2026 (France)
- Hormone Receptor-Positive Breast Cancer - Euro Breast Cancer 2025 (France)
- Hormone Receptor-Positive Subtypes - Breast Cancer-2026 (Italy)
- Immunotherapy and Breast Cancer - Breast Cancer-2026 (Italy)
- Immunotherapy and Emerging Targeted Therapies - Euro Breast Cancer 2025 (France)
- Immunotherapy in Breast Cancer - Breast Cancer-2026 (Italy)
- Inflammatory Breast Cancer - Breast Cancer 2026 (UAE)
- Innovations in Breast Cancer Treatment - Breast Cancer Summit 2026 (France)
- Innovations in Cancer Data and Informatics - CANCER THERAPY MEETING 2026 (France)
- Innovative Approaches in Cancer Radiology - CANCER THERAPY MEETING 2026 (France)
- Integration of Patient-Reported Outcomes in Cancer therapy - CANCER THERAPY MEETING 2026 (France)
- Liquid Biopsy and Early Cancer Detection - CANCER THERAPY MEETING 2026 (France)
- Liquid Biopsy and Non-Invasive Diagnostics - Breast Cancer-2026 (Italy)
- Male Breast Cancer Research - Breast Cancer 2026 (UAE)
- Mammography - Breast Cancer 2026 (UAE)
- Metastatic Breast Cancer Management - Breast Cancer-2026 (Italy)
- Metastatic Breast Cancer: Quality of Life and Care - Euro Breast Cancer 2025 (France)
- Molecular Diagnostics and Biomarkers in Cancer - CANCER THERAPY MEETING 2026 (France)
- Nanotechnology in Cancer Diagnosis and Treatment - CANCER THERAPY MEETING 2026 (France)
- Neoadjuvant and Adjuvant Therapies - Breast Cancer-2026 (Italy)
- Oncogenomics - Cancer Science 2026 (UAE)
- Oncology Nursing and Care - Cancer Science 2026 (UAE)
- Oncology Nursing: Advancements in Patient Care - CANCER THERAPY MEETING 2026 (France)
- Organic Specific Cancer - Cancer Science 2026 (UAE)
- Pediatric Cancer Research and Therapeutics - CANCER THERAPY MEETING 2026 (France)
- Precision Medicine and Genomics in Breast Cancer - Euro Breast Cancer 2025 (France)
- Psychosocial Aspects of Breast Cancer - Breast Cancer-2026 (Italy)
- Psychosocial Support and Survivorship - Breast Cancer Summit 2026 (France)
- Psychosocial Support and Survivorship in Breast Cancer - Euro Breast Cancer 2025 (France)
- Psychotherapy and Cancer - CANCER THERAPY MEETING 2026 (France)
- Radiation Oncology in Breast Cancer - Breast Cancer-2026 (Italy)
- Radiation Oncology: Innovations and Techniques - CANCER THERAPY MEETING 2026 (France)
- Radiation Therapy and Technological Innovations - Euro Breast Cancer 2025 (France)
- Radiation Therapy in Breast Cancer - Breast Cancer Summit 2026 (France)
- Radiology - Breast Cancer 2026 (UAE)
- Role of Microbiome in Cancer - CANCER THERAPY MEETING 2026 (France)
- Skin Cancer - Cancer Science 2026 (UAE)
- Surgical Advances in Breast Cancer Management - Euro Breast Cancer 2025 (France)
- Surgical Innovations in Breast Cancer - Breast Cancer-2026 (Italy)
- Surgical Oncology in Breast Cancer - Breast Cancer Summit 2026 (France)
- Targeted Therapy and Drug Development - Breast Cancer-2026 (Italy)
- Targeted Therapy and Precision Medicine - CANCER THERAPY MEETING 2026 (France)
- Triple-Negative Breast Cancer (TNBC) - Breast Cancer Summit 2026 (France)
- Triple-Negative Breast Cancer Research - Breast Cancer-2026 (Italy)
- Triple-Negative Breast Cancer: Challenges and Innovations - Euro Breast Cancer 2025 (France)
- Tumor Biology - Cancer Science 2026 (UAE)
- Tumor Microenvironment and Metastasis - CANCER THERAPY MEETING 2026 (France)
- Tumor Virology - Cancer Science 2026 (UAE)
- Young Women and Breast Cancer - Breast Cancer-2026 (Italy)